Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Sickle Cell Anemia in Children: later-stage trial registry
1 of 3 indexed Sickle Cell Anemia in Children trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Sickle Cell Anemia in Children: 3 US clinical trials tracked, 1 recruiting.
Sickle Cell Anemia in Children is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Phoenix Children's Hospital, running 1 of these trials.
Enrollment posture brief
Registry condition sickle-cell-anemia-in-children
OPEN 1 | RECR 33% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Sickle Cell Anemia in Children lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Sickle Cell Anemia in Children on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Sickle Cell Anemia in Children is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Low Systemic/High Local Exercise Load in Peds SCD
University of Mississippi Medical Center
NCT06387758
The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern Nigeria
Vanderbilt University Medical Center
NCT04800809
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
Phoenix Children's Hospital
NCT03176849
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Sickle Cell Anemia in Children records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Sickle Cell Anemia in Children trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Sickle Cell Anemia in Children page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Sickle Cell Anemia in Children trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Phoenix Children's Hospital sponsors the most Sickle Cell Anemia in Children trials on record, review their full trial history before evaluating a specific study. See Phoenix Children's Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sickle Cell Anemia in Children condition card totals 3 registered trials; most-linked intervention Standard Vitamin D3 Supplementation; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.